Cargando…

Predictive models for overall survival in breast cancer patients with a second primary malignancy: a real-world study in Shanghai, China

BACKGROUND: The incidents of second primary malignancy (SPM) is increasing among breast cancer (BC) patients with long-term progression, adversely affecting survival. The purpose of this study was to screen independent overall survival (OS) risk factors and establish nomograms to predict the surviva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ling, Chen, Yichen, Li, Xiaopan, Jin, Hua, Shi, Jianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724326/ https://www.ncbi.nlm.nih.gov/pubmed/36474253 http://dx.doi.org/10.1186/s12905-022-02079-0

Ejemplares similares

Overall survival and second primary malignancies in men with metastatic prostate cancer
por: Mehtälä, Juha, et al.
Publicado: (2020)

The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study
por: Li, Xiaopan, et al.
Publicado: (2019)

Urban-Rural Disparity in Cancer Incidence, Mortality, and Survivals in Shanghai, China, During 2002 and 2015
por: Li, Xiaopan, et al.
Publicado: (2018)

The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma
por: Ipek, Yildiz, et al.
Publicado: (2023)

Years of life lost due to premature death and their trends in people with malignant neoplasm of female genital organs in Shanghai, China during 1995–2018: a population based study
por: Luo, Zheng, et al.
Publicado: (2020)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Longitudinal analysis of ovarian cancer death patterns during a rapid transition period (2005-2020) in Shanghai, China: A population-based study
por: Li, Xiaopan, et al.
Publicado: (2022)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

Propensity score analysis of overall survival between first‐ and second‐generation EGFR‐TKIs using real‐world data
por: Ito, Kentaro, et al.
Publicado: (2020)

Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies
por: Jing, Yaoyao, et al.
Publicado: (2023)

Types of second primary cancer influence overall survival in cutaneous melanoma
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Association Between Metformin and Sulfonylurea Monotherapies and Cancer Incidence: A Real-World Cohort Study in Shanghai, China
por: Ye, Jing-Hong, et al.
Publicado: (2019)

Disability-adjusted life years and the trends of the burden of colorectal cancer: a population-based study in Shanghai, China during 2002 to 2016
por: Zhong, Wei, et al.
Publicado: (2022)

Multimorbid Patient Experiences With Primary Care at Community Health Centers in Shanghai, China
por: Jin, Hua, et al.
Publicado: (2021)

A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
por: Kerrigan, Kathleen, et al.
Publicado: (2022)

Years of Life Lost Due to Premature Death and Their Trends in People With Selected Neurological Disorders in Shanghai, China, 1995–2018: A Population-Based Study
por: Luo, Zheng, et al.
Publicado: (2021)

Evaluating the risk of hypertension in residents in primary care in Shanghai, China with machine learning algorithms
por: Chen, Ning, et al.
Publicado: (2022)

Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study
por: Liu, Yi, et al.
Publicado: (2021)

Second primary breast cancer after diagnosis of breast cancer among male patients: An examination of population characteristics and overall survival
por: Chowdhry, Amit K., et al.
Publicado: (2020)

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2022)

Survival for endometrial cancer as a second primary malignancy
por: Medina, Heidy N., et al.
Publicado: (2022)

Incidence and Overall Survival of Malignant Ameloblastoma
por: Rizzitelli, Alexandra, et al.
Publicado: (2015)

Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
por: Roszik, Jason, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting overall survival of patients with cancer of unknown primary: a real-world data analysis
por: Jin, Yizi, et al.
Publicado: (2021)

Diet and breast cancer in Shanghai and Tianjin, China.
por: Yuan, J. M., et al.
Publicado: (1995)

Influence of Demographic Factors on Long-Term Trends of Premature Mortality and Burden Due to Liver Cancer: Findings From a Population-Based Study in Shanghai, China, 1973–2019
por: Luo, Zheng, et al.
Publicado: (2022)

The quality of primary care in community health centers: comparison among urban, suburban and rural users in Shanghai, China
por: Shi, Jianwei, et al.
Publicado: (2020)

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
por: Ton, Thanh G.N., et al.
Publicado: (2022)

Second primary malignancies in patients with male breast cancer
por: Hemminki, K, et al.
Publicado: (2005)

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
por: Whitaker, Kristen D., et al.
Publicado: (2022)

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020
por: Zhang, Yichen, et al.
Publicado: (2022)

Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
por: Skelton, William P, et al.
Publicado: (2019)

Dynamic Prediction of Near-Term Overall Survival in Patients with Advanced NSCLC Based on Real-World Data
por: Wang, Xuechen, et al.
Publicado: (2022)

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
por: Su, Yung-Yeh, et al.
Publicado: (2023)

Fighting Omicron epidemic in China: Real-world big data from Fangcang shelter hospital during the outbreak in Shanghai 2022
por: Ye, Lingying, et al.
Publicado: (2022)

Machine learning algorithms to predict intraoperative hemorrhage in surgical patients: a modeling study of real-world data in Shanghai, China
por: Shi, Ying, et al.
Publicado: (2023)

Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survival
por: Antonini, Marcelo, et al.
Publicado: (2023)

Analysis and prediction of second primary malignancy in patients with breast cancer
por: Long, Quanyi, et al.
Publicado: (2022)

Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
por: Courtinard, Coralie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_amstqlko3ui8hnhec69qtkspk9